Tigecycline Patent Expiration
Tigecycline was first introduced by Pf Prism Cv
Tigecycline Patents
Given below is the list of patents protecting Tigecycline, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tigecycline | US9855335 | Tigecycline composition for injection | Apr 07, 2033 | Amneal |
| Tigecycline | US9855355 | Method and device for plasma-treating hollow bodies | Apr 07, 2033 | Amneal |
| Tygacil | US8372995 | Crystalline solid forms of tigecycline and methods of preparing same | Oct 08, 2030 | Pf Prism Cv |
| Tygacil | US7879828 | Tigecycline compositions and methods of preparation | Feb 05, 2029 | Pf Prism Cv |
| Tygacil | US8975242 | Tigecycline compositions and methods of preparation | Oct 24, 2028 | Pf Prism Cv |
| Tygacil | US10588975 | Tigecycline compositions and methods of preparation | Mar 13, 2026 | Pf Prism Cv |
| Tygacil | US9254328 | Tigecycline compositions and methods of preparation | Mar 13, 2026 | Pf Prism Cv |
| Tygacil | US9694078 | Tigecycline compositions and methods of preparation | Mar 13, 2026 | Pf Prism Cv |
| Tygacil | USRE40183 | 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
Apr 09, 2016
(Expired) | Pf Prism Cv |
| Tygacil | USRE40086 | Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines |
Jun 25, 2013
(Expired) | Pf Prism Cv |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Tigecycline's patents.
Latest Legal Activities on Tigecycline's Patents
Given below is the list recent legal activities going on the following patents of Tigecycline.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 11 Jul, 2024 | US8372995(Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Aug, 2023 | US10588975 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Jul, 2023 | US9254328 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Aug, 2022 | US8975242(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 13 Jul, 2022 | US7879828(Litigated) |
| Expire Patent Critical | 07 Feb, 2022 | US9855355 |
| Maintenance Fee Reminder Mailed Critical | 23 Aug, 2021 | US9855355 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 07 Jul, 2021 | US9855335 |
| Surcharge for late Payment, Small Entity | 07 Jul, 2021 | US9855335 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 11 Jun, 2021 | US9855335 |
Tigecycline's Family Patents
Explore Our Curated Drug Screens
Tigecycline Generic API Manufacturers
Several generic applications have been filed for Tigecycline. The first generic version for Tigecycline was by Sandoz Inc and was approved on May 27, 2015. And the latest generic version is by Meitheal Pharmaceuticals Inc and was approved on May 13, 2021.
Given below is the list of companies who have filed for Tigecycline generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Dec 21, 2018 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
2. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 11, 2019 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
3. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | powder | Prescription | INTRAVENOUS | AP | May 13, 2021 |
4. SANDOZ
Sandoz Inc has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | powder | Prescription | INTRAVENOUS | AP | May 27, 2015 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| Austria |
| |||||
| United States |
| |||||
| Spain |
| |||||
| India |
| |||||
5. XELLIA PHARMS APS
Xellia Pharmaceuticals Aps has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Xellia Pharms Aps.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Oct 18, 2019 |